Yale Surgeons to Present at International Surgical Oncology Conference

Yale Department of Surgery oncologists and trainees at Yale Cancer Center will present new findings at the Society of Surgical Oncology (SSO) Annual Meeting in Tampa, Fla., from March 27–29. The conference focuses on improving surgical cancer care for patients through educational sessions as well as oral and poster presentations for surgical oncologists, researchers, and patient advocates.

The 2025 program will feature research on breast, colorectal, endocrine, gastrointestinal, hepato-pancreato-biliary, melanoma, peritoneal, and sarcoma cancers. Yale presentations will address barriers to gastrointestinal cancer care, early-onset mutations in appendix cancer, and Tumor Infiltrating Lymphocyte (TIL) therapy for melanoma.

Yale Presentations

Thursday, March 27

• Samuel Butensky, MD

Self-Perceived Barriers to Healthcare Experienced by Patients with Gastrointestinal Cancers

• Elizabeth Godfrey, MD

Experiences and Decisional Outcomes After Cytoreductive Surgery for Peritoneal Surface Malignancy: A Survey from the DECISIVE Study

• Princy Gupta

PIK3CA Mutations are More Frequent in Early-Onset Appendiceal Cancer and Associated with Poorer Survival

• David Su, MD

CD45RO-Based Digital Spatial Proteomic Signatures Predict Immunotherapy Response in Melanoma

• Wendy Feng, MD

A Systematic Review of Surgical Care for Persons Experiencing Homelessness with Cancer

• Samuel Butensky, MD

Evaluation of Social Support, Discrimination, and Perceived Health in Patients with Gastrointestinal Tract Cancers

• Pathik Aravind

Comparison of Prediction Models for Postoperative Pancreatic Fistula Formation after Pancreaticoduodenectomy

• Leanne Brown, MD

Impact of Neoadjuvant Chemotherapy on Operative Outcomes Following Pancreaticoduodenectomy in Pancreatic Adenocarcinoma

Friday, March 28

• Kelly Olino, MD

TIL Therapy: What We’ve Learned in Melanoma and Future Applications to Other Disease Sites

• Sajid Khan, MD

Pushing Boundaries of Colorectal Liver Metastases Management: How Far Can We Go?

For interviews with Yale experts, contact Michael.Masciadrelli@yale.edu.